Insider · CIK 0001441500

Loren Stefan

Reports to the SEC for 5 companies · FLORHAM PARK, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001441500

Forms 4 and 5

Insider transactions

39 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-08	CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award	Consultant	AAward	+15K sh	—	—	15,000
2026-07-08	CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award	Consultant	AAward	+15K sh	—	—	15,000
2025-02-14	CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award	Consultant	AAward	+60K sh	—	—	60,000
2024-06-14	CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award	Consultant	AAward	+60K sh	—	—	60,000
2023-06-28	CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award	Consultant	AAward	+25K sh	—	—	47,885
2022-06-24	CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award	Consultant	AAward	+7,800 sh	—	—	7,800
2021-06-30	CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award	Consultant	AAward	+78K sh	—	—	78,000
2020-06-24	CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award	Consultant	AAward	+50K sh	—	—	50,000
2019-06-13	CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award	Consultant	AAward	+6,500 sh	—	—	6,500
2018-10-12	CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award	Consultant	AAward	+13K sh	—	—	13,000
2017-06-16	GENVEC INCM Exercise/Conversion	Director	MExercise/Conversion	+1,500 sh	$3.80	+$5,700	2,000
2017-06-16	GENVEC INCD Disposition to Issuer	Director	DDisposition to Issuer	−1,207 sh	—	—	0
2017-06-16	GENVEC INCStock Options (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,500 sh	$3.80	−$5,700	0
2017-05-31	CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award	Consultant	AAward	+10K sh	—	—	10,000
2017-01-03	ATRXAdhera Therapeutics, Inc. · Options to purchase common stockA Award	Director	AAward	+81K sh	—	—	81,000
2016-11-15	ATRXAdhera Therapeutics, Inc. · Options to purchase common stockA Award	Director	AAward	+35K sh	—	—	35,000
2016-10-20	GENVEC INCStock Options (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2016-07-05	CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award	Consultant	AAward	+22.5K sh	$0.01	+$225	23,500
2016-06-16	GENVEC INCF Tax Payment	Director	FTax Payment	−793 sh	$7.19	−$5,701.67	1,207
2016-01-04	ATRXAdhera Therapeutics, Inc. · Options to purchase common stockA Award	Director	AAward	+38K sh	—	—	38,000
2015-11-16	GENVEC INCP Purchase	Director	PPurchase	+3,600 sh	$1.93	+$6,945.12	4,600
2015-11-16	GENVEC INCP Purchase	Director	PPurchase	+100 sh	$1.93	+$192.65	4,700
2015-11-16	GENVEC INCP Purchase	Director	PPurchase	+100 sh	$1.93	+$192.65	4,800
2015-11-16	GENVEC INCP Purchase	Director	PPurchase	+100 sh	$1.93	+$192.6	4,900
2015-11-16	GENVEC INCP Purchase	Director	PPurchase	+100 sh	$1.93	+$192.6	5,000
2015-11-13	GENVEC INCStock Options (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2015-01-06	ATRXAdhera Therapeutics, Inc. · Options to purchase common stockA Award	Director	AAward	+38K sh	—	—	38,000
2014-12-31	GENVEC INCA Award	Director	AAward	+100 sh	$2.06	+$206	100
2014-12-31	GENVEC INCP Purchase	Director	PPurchase	+900 sh	$2.16	+$1,944	1,000
2014-12-31	GENVEC INCA Award	Director	AAward	+900 sh	$2.16	+$1,944	1,000
2014-12-31	GENVEC INCP Purchase	Director	PPurchase	+100 sh	$2.06	+$206	100
2014-12-05	GENVEC INCStock Options (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2014-09-15	ATRXAdhera Therapeutics, Inc. · Options to purchase common stockA Award	Director	AAward	+62K sh	—	—	62,000
2014-01-01	ATRXAdhera Therapeutics, Inc.A Award	Director	AAward	+181K sh	—	—	181,303
2013-11-22	GENVEC INCStock Options (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2013-09-19	GENVEC INCStock Options (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2012-03-26	POLYMEDIX, INCStock Option (Right to purchase)A Award	Director	AAward	+37K sh	—	—	37,000
2011-01-20	POLYMEDIX, INCStock Option (Right to purchase)A Award	Director	AAward	+25K sh	—	—	25,000
2010-09-02	POLYMEDIX, INCStock Option (Right to purchase)A Award	Director	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
Jul 104/A
Loren Stefan0001104659-26-082761
SEC(opens sec.gov)
Jul 84
Loren Stefan0001104659-26-082009
SEC(opens sec.gov)
Feb 184
Loren Stefan0001104659-25-014752
SEC(opens sec.gov)
Jun 184
Loren Stefan0001104659-24-072883
SEC(opens sec.gov)
Jun 284
Loren Stefan0001104659-23-075939
SEC(opens sec.gov)
Aug 14
Loren Stefan0001104659-22-084837
SEC(opens sec.gov)
Jul 24
Loren Stefan0001104659-21-088839
SEC(opens sec.gov)
Jun 254
Loren Stefan0001104659-20-076875
SEC(opens sec.gov)
Jun 144
Loren Stefan0001144204-19-031008
SEC(opens sec.gov)
Oct 154
Loren Stefan0001144204-18-053881
SEC(opens sec.gov)
Jun 204
GENVEC INC0001123292-17-001159
SEC(opens sec.gov)
Jun 14
Cellectar Biosciences, Inc.0001144204-17-030680
SEC(opens sec.gov)
Jan 44
Marina Biotech, Inc.0001493152-17-000142
SEC(opens sec.gov)
Nov 174
Marina Biotech, Inc.0001493152-16-015243
SEC(opens sec.gov)
Oct 244
GENVEC INC0001140361-16-083399
SEC(opens sec.gov)
Jul 74
Cellectar Biosciences, Inc.0001144204-16-111978
SEC(opens sec.gov)
Jan 54
Marina Biotech, Inc.0001441500-16-000002
SEC(opens sec.gov)

Companies

Address

C/O CELLECTAR BIOSCIENCES, INC. 100 CAMPUS DRIVE

FLORHAM PARK, NJ, 07932